Market Cap

Apontis Pharma AG Market Capitalization:

€39.8 Million

EUR as of Jan. 1, 2024

US$43.9 Million

business Apontis Pharma AG Company Profile

Apontis Pharma AG Main Stock Listings

Market Capitalization History of Apontis Pharma AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Apontis Pharma AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 €39.8 M -45.20%
Jan. 1, 2023 €72.6 M -50.62%
Jan. 1, 2022 €147.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Apontis Pharma AG Categories

Germany languages Healthcare languages Drug Manufacturers—Specialty & Generic
Germany Healthcare Germany Drug Manufacturers—Specialty & Generic

Stocks & Indices

Apontis Pharma AG has the following listings and related stock indices.


Stock: FSX: APPH

Stock: XETR: APPH

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.